CNTA
Centessa Pharmaceuticals
CNTA
CNTA
45 hedge funds and large institutions have $435M invested in Centessa Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 44 → 45 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
79% less call options, than puts
Call options by funds: $7K | Put options by funds: $33K
Holders
45
Holding in Top 10
3
Calls
$7K
Puts
$33K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$9.63M | |
| 3 | +$3.28M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.46M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$1.34M |
Top Sellers
| 1 | -$6.52M | |
| 2 | -$299K | |
| 3 | -$254K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$247K |
| 5 |
Jane Street
New York
|
-$155K |